LENZ Therapeutics, Inc. ( LENZ) - Key Metrics
LENZ Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.05 | -$1.16 | -$1.06 | -$1.06 |
| 2025Q3 | $0.44 | -$0.59 | -$0.30 | -$0.32 |
| 2025Q2 | $0.18 | -$0.53 | -$0.41 | -$0.42 |
| 2025Q1 | ? | -$0.53 | -$0.58 | -$0.59 |
LENZ Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -3.46 |
| 2025Q3 | ? | -19.90 |
| 2025Q2 | ? | -13.80 |
| 2025Q1 | ? | -12.10 |
LENZ Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -11.71% | ? |
| 2025Q4 | -6.65% | ? |
| 2025Q3 | -0.68% | ? |
| 2025Q2 | -1.43% | ? |
| 2025Q1 | -2.28% | ? |
LENZ
Price: $7.01
52 week price:
Earnings Per Share: -3.64 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 230.1 million